Patent · US Expired

Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics

US6265588A · kind A · utility

25Cited by

7References

8Claims

0Family size

Assignee

Aventis Pharma Deutschland GmbH · DE

Inventors

Stefan Mullner · Langenfeld, DE
Bernd Kirschbaum · Mainz, DE
Wilfried Schwab · Altentreptow, DE

Key dates

Filing date	May 30, 2000
Grant date	Jul 24, 2001
Priority date	—
Expiry date	May 30, 2020

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/94
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A compound of the formula ##STR1## where R.sup.1 is the radical of the formula II or III ##STR2## is suitable for the production of a pharmaceutical for the treatment of inflammations, carcinomatous diseases, or autoimmune diseases. A compound of the formula IV ##STR3## is suitable for the production of specific antibodies against a compound of the formula I for the discovery of specific-binding proteins from cell extracts, serum, blood, or synovial fluids, for the purification of proteins, for the modification of microtiter plates, or for the preparation of chromatography material, in particular of affinity chromatography material, and for use in diagnostics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.